File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Antiproliferative effect of arsenic trioxide in non-small cell lung carcinoma (NSCLC)

TitleAntiproliferative effect of arsenic trioxide in non-small cell lung carcinoma (NSCLC)
Authors
Lam, SKZheng, CHo, JCM
KeywordsArsenic trioxide
Non-small cell lung cancer
Issue Date2011
PublisherLippincott Williams & Wilkins.
Citation
The 14th World Conference on Lung Cancer (WCLC 2011), Amsterdam, The Netherlands, 3-7 July 2011. In Journal of Thoracic Oncology, 2011, v. 6 suppl. 2, bk 2, p. S932-S933, abstract no. P2.022 How to Cite?
DOI: http://dx.doi.org/10.1097/01.JTO.0000399290.73317.eb
AbstractBACKGROUND: Arsenic trioxide (ATO) has been proven to be an effective treatment in acute promyelocytic leukemia and its activity has also been noted in some other solid tumors. The objectives of this study were to examine the in vitro effects of ATO in cell proliferation and the molecular mechanisms underlying the ATO induced cellular responses in NSCLC cell ...
DescriptionThis journal suppl. divided into 2 bks entitled Proceedings of the 14th World Conference on Lung Cancer 2011
Poster Session 2 – Preclinical Models
Persistent Identifierhttp://hdl.handle.net/10722/137780
ISSN
1556-0864
2021 Impact Factor: 20.121
2020 SCImago Journal Rankings: 4.539

 

DC FieldValueLanguage
dc.contributor.authorLam, SKen_US
dc.contributor.authorZheng, Cen_US
dc.contributor.authorHo, JCMen_US
dc.date.accessioned2011-08-26T14:33:16Z-
dc.date.available2011-08-26T14:33:16Z-
dc.date.issued2011en_US
dc.identifier.citationThe 14th World Conference on Lung Cancer (WCLC 2011), Amsterdam, The Netherlands, 3-7 July 2011. In Journal of Thoracic Oncology, 2011, v. 6 suppl. 2, bk 2, p. S932-S933, abstract no. P2.022en_US
dc.identifier.issn1556-0864-
dc.identifier.urihttp://hdl.handle.net/10722/137780-
dc.descriptionThis journal suppl. divided into 2 bks entitled Proceedings of the 14th World Conference on Lung Cancer 2011-
dc.descriptionPoster Session 2 – Preclinical Models-
dc.description.abstractBACKGROUND: Arsenic trioxide (ATO) has been proven to be an effective treatment in acute promyelocytic leukemia and its activity has also been noted in some other solid tumors. The objectives of this study were to examine the in vitro effects of ATO in cell proliferation and the molecular mechanisms underlying the ATO induced cellular responses in NSCLC cell ...-
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins.-
dc.relation.ispartofJournal of Thoracic Oncologyen_US
dc.subjectArsenic trioxide-
dc.subjectNon-small cell lung cancer-
dc.titleAntiproliferative effect of arsenic trioxide in non-small cell lung carcinoma (NSCLC)en_US
dc.typeConference_Paperen_US
dc.identifier.emailLam, SK: sklam77@hku.hken_US
dc.identifier.emailZheng, C: alds324@hku.hken_US
dc.identifier.emailHo, JCM: jhocm@hku.hk-
dc.identifier.authorityHo, JCM=rp00258en_US
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1097/01.JTO.0000399290.73317.eb-
dc.identifier.hkuros190425en_US
dc.identifier.volume6-
dc.identifier.issuesuppl. 2, bk 2-
dc.identifier.spageS932, abstract no. P2.022-
dc.identifier.epageS933-
dc.publisher.placeUnited States-
dc.customcontrol.immutablesml 130802-
dc.identifier.issnl1556-0864-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats